Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

INVENTURUS KNOWLEDGE SOLUTIONS (IKS.BO)

1,476.80
-5.30
(-0.36%)
At close: April 30 at 3:29:57 PM GMT+5:30
Loading Chart for IKS.BO
  • Previous Close 1,482.10
  • Open 1,499.95
  • Bid 1,455.00 x --
  • Ask 1,478.00 x --
  • Day's Range 1,457.45 - 1,552.45
  • 52 Week Range 1,226.15 - 2,190.00
  • Volume 32,242
  • Avg. Volume 8,481
  • Market Cap (intraday) 246.84B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 61.35
  • EPS (TTM) 24.07
  • Earnings Date May 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1,485.00

Inventurus Knowledge Solutions Limited operates as a technology-enabled healthcare solutions provider. The company offers a care enablement platform that assists physician enterprises in outpatient and inpatient care activities in the United States, Canada, and Australia. Its platform serves healthcare organizations, including health systems, academic medical centers, multi-specialty medical groups, single-specialty medical groups, ancillary healthcare organizations, and other outpatient healthcare delivery organizations. The company was incorporated in 2006 and is based in Navi Mumbai, India.

ikshealth.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: IKS.BO

View More

Performance Overview: IKS.BO

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

IKS.BO
22.96%
S&P BSE SENSEX (^BSESN)
2.69%

1-Year Return

IKS.BO
20.43%
S&P BSE SENSEX (^BSESN)
7.73%

3-Year Return

IKS.BO
20.43%
S&P BSE SENSEX (^BSESN)
40.63%

5-Year Return

IKS.BO
20.43%
S&P BSE SENSEX (^BSESN)
137.98%

Compare To: IKS.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IKS.BO

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    246.74B

  • Enterprise Value

    253.38B

  • Trailing P/E

    61.26

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.62

  • Price/Book (mrq)

    17.92

  • Enterprise Value/Revenue

    9.90

  • Enterprise Value/EBITDA

    35.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.70%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    25.6B

  • Net Income Avi to Common (ttm)

    4.02B

  • Diluted EPS (ttm)

    24.07

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.71B

  • Total Debt/Equity (mrq)

    67.88%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: IKS.BO

View More

Company Insights: IKS.BO

Research Reports: IKS.BO

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.